LOGIN  |  REGISTER
Amneal Pharmaceuticals

Recent Insider Transactions - BridgeBio Pharma (NASDAQ: BBIO)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ BBIO BridgeBio Pharma
KKR Genetic Disorder L.P. / 10 percent owner
09/13/2024
Sell
$25.75
5.80M
$149.350M
25.26M
NASDAQ BBIO BridgeBio Pharma
Kumar Neil / director, officer: Chief Executive Officer
08/19/2024
Sell
$25.13
11,197
$281K
4.90M
NASDAQ BBIO BridgeBio Pharma
Kumar Neil / director, officer: Chief Executive Officer
08/19/2024
Sell
$24.39
16,192
$395K
4.90M
NASDAQ BBIO BridgeBio Pharma
STEPHENSON BRIAN C / officer: Secretary, Treasurer & CFO
08/19/2024
Sell
$24.39
2,457
$60K
86,890
NASDAQ BBIO BridgeBio Pharma
STEPHENSON BRIAN C / officer: Secretary, Treasurer & CFO
08/19/2024
Sell
$25.13
1,698
$43K
85,192

COPYRIGHT ©2023 HEALTH STOCKS HUB